The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds
- PMID: 15276427
- DOI: 10.1016/j.taap.2003.10.023
The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds
Abstract
Excess intake of arsenic is known to cause vascular diseases as well as skin lesions and cancer in humans. Recent reports suggest that trivalent methylated arsenicals, which are intermediate metabolites in the methylation process of inorganic arsenic, are responsible for the toxicity and carcinogenicity of environmental arsenic. We investigated acute toxicity and accumulation of monomethylarsonic acid (MMA(V)), dimethylarsinic acid (DMA(V)), trimethylarsine oxide (TMAO), and monomethylarsonous acid diglutathione (MMA(III) (GS)(2)) in rat heart microvessel endothelial (RHMVE) cells. MMA(V) (LC(50) = 36.6 mM) and DMA(V) (LC(50) = 2.54 mM) were less toxic than inorganic arsenicals (cf. LC(50) values for inorganic arsenite (iAs(III)), and inorganic arsenate (iAs(V)) was reported to be 36 and 220 microM, respectively, in RHMVE cells. TMAO was essentially not toxic. However, MMA(III) (GS)(2) was highly toxic (LC(50) = 4.1 microM). The order of cellular arsenic accumulation of those four organic arsenic compounds was MMA(III) (GS)(2) >> MMA(V) > DMA(V) > TMAO. MMA(III) (GS)(2) was efficiently taken up by the cells and cellular arsenic content increased with the concentration of MMA(III) (GS)(2) in culture medium. N-acetyl-l-cysteine (NAC) reduced cellular arsenic content in DMA(V)-exposed cells and also decreased the cytotoxicity of DMA(V), whereas it changed neither cellular arsenic content nor the viability in MMA(V)-exposed cells. mRNA levels of heme oxygenase-1 (HO-1) were decreased by NAC in DMA(V)-exposed, but MMA(V)-exposed cells. Buthionine sulfoximine (BSO), a cellular glutathione (GSH) depleting agent, enhanced the cytotoxicity of MMA(V). However, BSO reduced, rather than enhanced, the cytotoxicity of DMA(V). These results suggest that intracellular GSH modulated the toxic effects of arsenic in opposite ways for MMA(V) and DMA(V). Even though intracellular GSH decreased the cytotoxicity of MMA(V), extracellularly added GSH enhanced the cytotoxicity of MMA(V). The use of high-performance liquid chromatography (HPLC)-inductively coupled plasma mass spectrometric analyses suggested that a small amount of MMA(V) was converted to MMA(III) (GS)(2) in the presence of GSH. These results suggest that MMA(III) (GS)(2) is highly toxic compared to other arsenic compounds because of faster accumulation of this species by cells, in addition to having the toxic nature of methylated trivalent organic arsenics.
Similar articles
-
Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.Toxicol Appl Pharmacol. 2004 Dec 1;201(2):156-65. doi: 10.1016/j.taap.2004.05.017. Toxicol Appl Pharmacol. 2004. PMID: 15541755
-
Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.Toxicol Sci. 2005 Sep;87(1):46-56. doi: 10.1093/toxsci/kfi218. Epub 2005 Jun 9. Toxicol Sci. 2005. PMID: 15947026
-
Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.Chem Res Toxicol. 2011 Sep 19;24(9):1586-96. doi: 10.1021/tx200291p. Epub 2011 Aug 16. Chem Res Toxicol. 2011. PMID: 21815631
-
A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):327-35. doi: 10.1016/j.taap.2003.10.027. Toxicol Appl Pharmacol. 2004. PMID: 15276412 Review.
-
Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.Crit Rev Toxicol. 2006 Feb;36(2):99-133. doi: 10.1080/10408440500534230. Crit Rev Toxicol. 2006. PMID: 16736939 Review.
Cited by
-
Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice.Arch Toxicol. 2019 Jan;93(1):25-35. doi: 10.1007/s00204-018-2332-7. Epub 2018 Oct 24. Arch Toxicol. 2019. PMID: 30357543 Free PMC article.
-
Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.Environ Health. 2013 Dec 9;12:107. doi: 10.1186/1476-069X-12-107. Environ Health. 2013. PMID: 24321145 Free PMC article.
-
Expression Of Selected Pathway-Marker Genes In Human Urothelial Cells Exposed Chronically To A Non-Cytotoxic Concentration Of Monomethylarsonous Acid.Toxicol Rep. 2014;1:421-434. doi: 10.1016/j.toxrep.2014.07.004. Toxicol Rep. 2014. PMID: 25177542 Free PMC article.
-
Analytical techniques for arsenic speciation.Anal Sci. 2025 Apr;41(4):317-321. doi: 10.1007/s44211-025-00722-y. Epub 2025 Jan 31. Anal Sci. 2025. PMID: 39890761 Free PMC article. Review.
-
Biogeochemical behavior and pollution control of arsenic in mining areas: A review.Front Microbiol. 2023 Mar 23;14:1043024. doi: 10.3389/fmicb.2023.1043024. eCollection 2023. Front Microbiol. 2023. PMID: 37032850 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical